THERAPEUTIC PROTEIN AND TREATMENTS

The present invention relates to microbial (antibacterial and antifungal) and other therapeutic treatments for diseases, in particular but not limited to the intestine, based upon angiogenins, and particularly angiogenin-4: a novel intestine-specific, epithelial-based, microbially-regulated member o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOOPER, LAURA, VIRGINIA, HONG, CHIEU, VI, GORDON, JEFFREY, IVAN, STAPPENBECK, THADDEUS, SMITH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to microbial (antibacterial and antifungal) and other therapeutic treatments for diseases, in particular but not limited to the intestine, based upon angiogenins, and particularly angiogenin-4: a novel intestine-specific, epithelial-based, microbially-regulated member of the angiogenin family. Novel proteins as well as their use in screening for pharmaceuticals are also described. La présente invention concerne des traitements microbiens (antibactériens et antifongiques) et d'autres traitements thérapeutiques pour des maladies, en particulier de l'intestin, à base d'angiogénines, en l'occurrence d'angiogénine-4. Cette dernière, qui est la spécificité de l'invention est un membre de la famille des angiogénines, spécifique de l'intestin, à base épithéliale, et à régulation microbienne. L'invention concerne également des protéines ainsi que leur utilisation pour la recherche systématique de produits pharmaceutiques.